An overview of our treatment centers follows with links to more comprehensive information at our sites of care.

Neuro-oncology

The neuro-oncology treatment centers provide consultation; state-of-the-art diagnosis and treatment, including investigational therapies; and long-term, follow-up care for patients with benign (non-cancerous) or malignant (cancerous) tumors of the central nervous system.

Patients include individuals with primary tumors, such as gliomas (astrocytomas, glioblastomas, brain stem gliomas, ependymomas, or oligodendrogliomas), pituitary adenomas, medulloblastomas, meningiomas, schwannomas, craniopharyngiomas, germ cell tumors, and pineal region tumors, as well as those with tumors that are secondary (that have spread) and nervous system lymphomas.

The patient's multidisciplinary care team involves specialists in neurosurgery, neurology, neuro-oncology, medical oncology, radiation oncology, neuropathology, and psychiatry, as well as oncology nurses and other healthcare professionals dedicated to the unique needs of patients with brain tumors. Patients also have access to a brain tumor support group.

These centers offer patients access to the latest surgical and radiologic therapies. Patients also have access to a wide range of novel therapies, including clinical trials, in chemotherapy, radiation therapy, and surgery, as well as immunotherapy and other therapeuic approaches.

Massachusetts General Hospital Cancer Center
Dana-Farber/Brigham and Women's Cancer Center